US FDA Neurology Drugs Program Gains Boost In FY 2023 Funding Bill Amid Calls To Clarify Development Policies
US FDA gains a nearly 7% increase in non-user fee funding, some of which will go for neurology drug guidance.
US FDA gains a nearly 7% increase in non-user fee funding, some of which will go for neurology drug guidance.